Ansgar Schuffenhauer1, Simon Ruedisser, Andreas L Marzinzik
1Novartis Institutes of Biomedical Research, CH-4002 Basel, Switzerland. ansgar.schuffenhauer@novartis.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Screening small molecular fragments with high sensitivity, such as with Nuclear Magnetic Resonance (NMR) screening, yields higher hit rates for detecting ligand binding compared to traditional high-throughput screening (HTS) of larger molecules. This approach optimizes fragment libraries for drug discovery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: